Volpara Health launches Professional Services to accelerate success for high-risk cancer programs
Friday, September 23, 2022
Services optimize risk assessment programs to improve workflow, foster greater
participation, and find cancers earlier
SEATTLE, Sept. 20, 2022 /PRNewswire/ -- Volpara Health (ASX: VHT), a global leader in software for the early detection of breast cancer, today announced the launch of its new comprehensive Professional Services offering to help its Risk Pathways customers maximize the value of their high-risk cancer assessment programs.
Volpara® Risk Pathways(TM) software has been used by more than 1,000 providers across the United States to identify, manage, and improve outcomes for patients at elevated risk for developing cancer.
Prominent medical associations now recommend risk assessment as a strategy to help detect breast cancer earlier, when it is more treatable.(1 )Accordingly, more and more healthcare providers are instituting high-risk programs to identify at a younger age those women who will benefit from additional screening and prevention techniques. As setting up a high-risk program can involve many challenges, breast care providers can benefit from the specialized expertise and support required to establish a program and achieve their clinical, financial, and operational goals. From inception to optimization, Volpara Professional Services helps programs achieve long-term success, offering expertise across the spectrum of essential program elements:
-- Strategy development
-- Program implementation
-- Workflow optimization
-- Physician and staff alignment
-- Patient education
-- Marketing support
-- Program evaluation
-- Return-on-investment frameworks
"Our mission is to help our customers save more families from cancer," said Teri Thomas, CEO of Volpara Health. "Despite the rise in high-risk programs, most patients are unaware of their risk status. We designed Professional Services to help providers remove roadblocks that may keep them from providing more effective, personalized care. Our Professional Services team features experienced professionals who previously managed their own programs. They bring decades of expertise in supporting leading clinical sites around the world, skillfulness and dedication that can help programs at each step and empower them to keep pace with rapidly changing risk assessment and genetic landscapes."
To learn more about how to launch, optimize, or expand your risk assessment program, visit Volpara Health at https://www.volparahealth.com/professional-services.
1. https://www.eradimaging.com/cffm/custom/2021/July2021/July_T8.jpg
Volpara Health makes software to save families from cancer. Healthcare providers use Volpara to better understand cancer risk, empower patients in personal care decisions, and guide recommendations about additional imaging, genetic testing, and other interventions. Our AI-powered image analysis enables radiologists to quantify breast tissue with precision and helps technologists produce mammograms with optimal image quality, positioning, compression, and dose. In an industry facing increasing staffing shortages, our software streamlines operations and provides key performance insights that support continuous quality improvement.
Volpara is the preferred partner of leading healthcare institutions around the world. Our software is used in over 2,000 facilities by more than 5,000 technologists, impacting nearly 15 million patients globally. It helps providers conduct more than three million cancer risk assessments each year and can be deployed stand-alone or fully integrated with electronic health record systems, mammography reporting systems, imaging hardware, and genetic laboratories. Volpara holds the most rigorous security certifications and numerous patents and regulatory registrations, including FDA clearance and CE marking. Since listing on the ASX in April 2016, the Company has raised A$132 million. With offices in Seattle and Boston, Volpara is based in Wellington, New Zealand.
For more information, visit www.volparahealth.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/volpara-health-launches-professional-services-to-accelerate-success-for-high-risk-cancer-programs-301628663.html
SOURCE Volpara Health
|
|
|
|
|
 |
Energy Toolbase Launches Energy Storage Partnership with Sungrow to Support PowerStack 255CS and PowerTitan 2.0 | Jan 22, 2026
|
|
Einride and IonQ Partnership Uses Quantum Computing to Optimize the Logistics of Electric and Autonomous Freight | Jan 22, 2026
|
|
RS now offers Phoenix Contact's pioneering new NearFi technology | Jan 22, 2026
|
|
SCAILIUM Debuts "AI Production Layer" to Overcome GPU Starvation and Slash AI Energy Waste | Jan 22, 2026
|
|
MetaOptics to Showcase Five Breakthrough Metalens-Powered Products at CES 2026 | Jan 22, 2026
|
|
No Assembly Required: Barrett Distribution Centers Powers Maxwood Furniture's West Coast DTC Expansion | Jan 22, 2026
|
|
Quantum Art Raises $100 Million in Series A Round to Drive Scalable, Multi-Core Quantum Computing | Jan 22, 2026
|
|
TESSAN to Redefine Global Mobility at CES 2026 with '100 Travelers' Initiative and Flagship Voyager 205 | Jan 22, 2026
|
|
Hesai Recognized as the Only Lidar Company on Morgan Stanley's "Humanoid Tech 25" of Global Robotics Leaders | Jan 22, 2026
|
|
1inch Named Exclusive Swap Provider at Launch for Ledger Multisig | Jan 22, 2026
|
|
|
